Navigation Links
Questcor Pharmaceuticals Reports Strong Finish to 2011
Date:1/6/2012

  • Our reliance on Acthar for substantially all of our nets sales and profits;
  • Reductions in vials used per prescription resulting from changes in treatment regimens by physicians or patient compliance with physician recommendations;
  • The complex nature of our manufacturing process and the potential for supply disruptions or other business disruptions;
  • The lack of patent protection for Acthar; and the possible FDA approval and market introduction of competitive products;
  • Our ability to generate revenue from sales of Acthar to treat on-label indications associated with nephrotic syndrome, and our ability to develop other therapeutic uses for Acthar including SLE;
  • Research and development risks, including risks associated with Questcor's work in the area of nephrotic syndrome and potential work in the area of SLE, and our reliance on third-parties to conduct research and development and the ability of research and development to generate successful results;
  • Regulatory changes or other policy actions by governmental authorities and other third parties in connection with U.S. health care reform or efforts to reduce federal and state government deficits;
  • Our ability to receive high reimbursement levels from third party payers;
  • An increase in the proportion of our Acthar unit sales comprised of Medicaid-eligible patients and government entities;
  • Our ability to estimate reserves required for Acthar used by government entities and Medicaid-eligible patients and the impact that unforeseen invoicing of historical Medicaid prescriptions may have upon our results;
  • Our ability to operate within an industry that is highly regulated at both the Federal and state level;
  • Our ability to effectively manage our growth, including the expansion of our NS selling effort, and our reliance on key personnel;
  • The impact to Questcor's busine
    '/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Questcor Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference on November 30, 2011
2. Questcor Pharmaceuticals to Present at CLSAs 4th Annual AsiaUSA Forum on November 7, 2011
3. Questcor and Child Neurology Foundation Support the 3rd Annual Infantile Spasms (IS) Awareness Week
4. Questcor Reports Third Quarter Financial Results
5. Questcor to Report Third Quarter 2011 Earnings and Conduct Conference Call on October 25, 2011
6. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
7. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
8. Questcor Provides Updated New Paid Prescription Trends
9. UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
10. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
11. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... -- China,s startup business ExtantFuture ... wearable medical device that can continuously monitor the fetal ... guidance for pregnant women. The device will debut on ... measures 4 centimeters in diameter, is as thin as ... an Apple earphone cord. The small and compact device ...
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... announced the addition of the "Diabetes Care Devices ... Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing ... Forecast to 2020" report to their offering. ... to be valued at USD 1.7 Billion in 2015 ...
(Date:9/3/2015)... , Sept. 3, 2015  VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, announced today, they are collaborating ... a new philanthropic, epidemiology study partnering with the ... .  VirtualScopics has teamed up with a cardiac ... The image results will be used to identify ...
Breaking Medicine Technology:Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4
... Similar to Seven-Day in, Achieving Red Blood Cell Transfusion Independence, ... ... Data Presented at the 49th American Society of Hematology (ASH) ... ) today announced interim data from a Phase 2 clinical ...
... of Severe Cardiac Toxicity With Equivalent ... Complete Remission Rates ... (Nasdaq and MTAX: CTIC) announced today that preliminary data ... in the,first-line treatment of patients with aggressive non-Hodgkin,s lymphoma,(NHL) ...
Cached Medicine Technology:MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 2MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 3MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 4MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 5MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 6Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5
(Date:9/3/2015)... ... 2015 , ... Silverado next week lays the foundation on ... Bellingham, Washington. Silverado Bellingham, a 41,000 square foot, single-story community, is expected to ... 80 people living with Alzheimer’s, dementia and other memory-impairing conditions. , Site ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... desktop solution for LANDESK Management Suite customers, as part of the LANDESK ... approach to IT, by delivering the best mobile user experience in remote access ...
(Date:9/3/2015)... ... , ... Girl’s Night Out to benefit Core Compassion Project will be held ... in Monroe, North Carolina. The event food will be provided by Kate ... offers off-premise catering and event services from casual to elegant. They are also the ...
(Date:9/3/2015)... ... September 03, 2015 , ... B. E. Smith, ... retained to lead a national chief executive officer recruitment for Melissa ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
(Date:9/3/2015)... ... 03, 2015 , ... As a result of the Patient ... health insurance plans, more employers are moving to a self-funded model for pharmacy ... 2014 United Benefit Advisors (UBA) Health Plan Survey. , UBA’s survey, the nation’s ...
Breaking Medicine News(10 mins):Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4
... a cardiac department in Mackay. //The report has brought to ... this hospital, which does not support a cardiac care unit ... the treatment, especially for heart attack patients or for those ... Hospital was found to meet the expectations to an extent ...
... The ability to identify an individual’s specific tumor type ... management of patients diagnosed with kidney cancer.// A newly ... (PET) using a radiolabeled antibody accurately identifies whether a ... common and aggressive type of renal tumor – and ...
... Tihar Jail in the national capital has increased three-fold in ... ,In 2006, 36 inmates were found suffering from ... State for Home Affairs S. Regupathy told the Rajya Sabha ... are being organised by the jail administration to rule out ...
... biomedical facility and Ely Lily, a drug company, claims ... help prevent relapses and reduce the effects of hangovers. ... action of the brain chemical Cortico tropin-Releasing Factor (CRF), ... two institutions. The results, as revealed in the Journal ...
... North America’s daylight savings time starts 3 weeks earlier ... one is the probable malfunctioning of medical devices, which ... warnings not only to individuals that own or are ... rely on time dependent and network information systems. ...
... recent bird flu outbreak has been reported in a duck ... on Tuesday and it was confirmed as bird flu on ... virus. ,It is the seventh bird flu outbreak ... cause of the six previous outbreaks in Korea. ...
Cached Medicine News:Health News:PET Imaging Identifies Aggressive Kidney Cancers That Require Surgery 2Health News:PET Imaging Identifies Aggressive Kidney Cancers That Require Surgery 3
... wealth of benefits to healthcare professionals and patients. ... a complete lipid profile and glucose, ALT, AST, ... 5 minutes per test cassette (6 minutes for ... click here ., ,The accuracy, speed and ...
The Lifestream Plus Cholesterol Monitor provides you with a comprehensive tool to help you monitor your cholesterol as part of your wellness program....
... Precision Xtra is easy ... to test more efficiently. Like ... all the benefits of TrueMeasure™ ... test results and the Precision ...
... Multiple blood chemistry testing. One-step testing. Average ... thirty day. Storage of up to 250 ... Automatic shut-off in two minutes from non-use ... Chip (included with each strip package). Results ...
Medicine Products: